Diskussionsleiter: C. E. Angermann (Würzburg), S. Störk (Würzburg)
| (P380) | Beneficial effect of preoperative IABP in low LVEF patients undergoing CABG |
| G. Santarpino, S. Pfeiffer, G. Concistré, F. Nabawi, J. Sirch, T. Fischlein (Nürnberg) | |
| (P381) | Should we operate patients with ischemic cardiomyopathy and severe mitral valve dysfunction? |
| J. Garbade, R. Kluttig, J. Seeburger, D. R. Merk, S. Lehmann, P. Davierwala, M. A. Borger, F. W. Mohr (Leipzig) | |
| (P382) | Surgical restoration of dyskinetic anteroapical left ventricular aneurysm supported with multi-slice computed tomography: update of single center experience |
| N. Solowjowa, A. Penkalla, M. Dandel, M. Pasic, R. Hetzer, C. Knosalla (Berlin) | |
| (P383) | Offpump technique for LV reconstruction, without ventriculotomy. A single center experience using the catheter based ReviventTM Myocardial Anchoring System (BioVentrix Inc.) in an EU clinical trial. |
| G. Kalinauskas, K. Rucinskas, R. Samalavicius, I. Norkiene, V. Janasauskas, L. Annest, A. Wechsler (Vilnius, LT; San Ramon, Philadelphia, US) | |
| (P384) | Early Versus Late Ventricular Assist Device Implantation in Patients Awaiting Cardiac Transplantation |
| C. Knosalla, H. Liptau, T. Friede, G. Hasenfuß, R. Hetzer for the DZHK Early VAD Study Group DZHK Heart Failure Program Group (Berlin, Göttingen) | |
| (P385) | Percutaneous Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy: Long-term Outcome |
| C. Prinz, L. Faber, M. Schumann, A. Burghardt, H. Seggewiß, D. Horstkotte (Bad Oeynhausen, Schweinfurt) | |
| (P386) | Kardiale Kontraktilitätsmodulation – Klinischer Langzeitverlauf: Ergebnisse einer Single-Center-Studie. |
| J. Kuschyk, S. Röger, R. Pirzer, V. Liebe, F. Streitner, B. Rudic, R. Schimpf, M. Borggrefe (Mannheim) | |
| (P387) | Minimally-invasive left ventricular assist device implantation: Lower mortality and improved early outcome in adult patients with severe heart failure |
| J. D. Schmitto, S. V. Rojas, M. Avsar, D. Berliner, J. S. Hanke, L. Fischer, A. Meyer, L. Repges, T. Thoms, J. Bauersachs, A. Haverich (Hannover) | |
| (P388) | Survival after extracorporeal life support in cardiogenic shock patients at a non-cardiac transplant center |
| D. Schibilsky, C. Haller, T. Krüger, H. Häberle, A. May, T. Walker, C. Schlensak (Tübingen) | |
| (P389) | Wurde vom Autor zurückgezogen: Impact of Load Dependency of Right Ventricular Performance on Decision Making Before Ventricular Assist Device Implantation |
| M. Dandel, E. Potapov, T. Krabatsch, A. Stepanenko, C. Knosalla, R. Hetzer (Berlin) | |
| (P390) | Survival of LVAD Implantation after extracorporeal life support |
| D. Schibilsky, C. Haller, T. Krüger, A. May, T. Walker, C. Schlensak (Tübingen) | |
| (P391) | Left Ventricular Assist Device (LVAD) Re-Implantation due to Heart Failure Reccurence after previous LVAD Weaning |
| A. Stepanenko, J. Vierecke, N. Dranishnikov, B. Jurmann, E. Potapov, M. Dandel, M. Kukucka, Y. Weng, M. Pasic, T. Krabatsch, R. Hetzer (Berlin) | |
| (P392) | Prognostic Effect of Coronary Artery Bypass Surgery or Heart Transplantation on Outcome in Patients with Ischemic Cardiomyopathy |
| N. E. Hiemann, A. Trogisch, P. Zarubova, M. Bauer, M. Pasic, R. Hetzer (Berlin) | |
| (P393) | Baroreflex Activation Therapy Improves NTproBNP and 6-Minute Walk Distance in Patients with Heart Failure and Reduced Ejection Fraction |
| M. Halbach, T. Hickethier, N. Madershahian, M.-C. Brandt, D. Ladage, R. Velden, E. Lovett, U. C. Hoppe, J. Müller-Ehmsen (Köln; Salzburg, AT; Minneapolis, US) | |
| (P394) | Neither norepinephrine nor dopamine pretreatment of heart donors leads to a better survival of heart transplant recipients |
| F. von Ziegler, S. Helbig, N. Kreißl, B. Meiser, A. Becker, I. Kaczmarek (München) | |
| (P395) | Plasmapheresis for management of patients with heparin-induced thrombocytopenia (HIT-II) undergoing cardiac surgery with cardiopulmonary bypass |
| M. Breuer, T. Sandhaus, S. Rummler, T. Steinke, D. Barz, T. Doenst (Jena) | |
| (P396) | Autologous muscular treatment options for endstage heart failure- A critical appraisal of the dynamic cardiomyoplasty (DCMP) vs. A new concept of a closed-loop controlled DCMP (CLC-DCMP) |
| N. Guldner, P. Klapproth, H.-H. Sievers (Lübeck) | |
| (P397) | 5-Year Results of a Calcineurininhibitor-free immunosuppression protocol (Sirolimus/MMF) compared to Tacrolimus with Mycophenolate Mofetil (MMF) or Sirolimus after heart transplantation |
| M.-M. Zaruba, I. Kazcmarek, R. Reimann, B. Meiser (München) |